495 related articles for article (PubMed ID: 31836967)
1. Actions of Trace Amines in the Brain-Gut-Microbiome Axis via Trace Amine-Associated Receptor-1 (TAAR1).
Bugda Gwilt K; González DP; Olliffe N; Oller H; Hoffing R; Puzan M; El Aidy S; Miller GM
Cell Mol Neurobiol; 2020 Mar; 40(2):191-201. PubMed ID: 31836967
[TBL] [Abstract][Full Text] [Related]
2. TAAR1 as an emerging target for the treatment of psychiatric disorders.
Liu J; Wu R; Li JX
Pharmacol Ther; 2024 Jan; 253():108580. PubMed ID: 38142862
[TBL] [Abstract][Full Text] [Related]
3. The Brain-Gut-Microbiome Axis in Psychiatry.
Jang SH; Woo YS; Lee SY; Bahk WM
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992484
[TBL] [Abstract][Full Text] [Related]
4. In-vivo pharmacology of Trace-Amine Associated Receptor 1.
Lam VM; Espinoza S; Gerasimov AS; Gainetdinov RR; Salahpour A
Eur J Pharmacol; 2015 Sep; 763(Pt B):136-42. PubMed ID: 26093041
[TBL] [Abstract][Full Text] [Related]
5. Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases.
Schwartz MD; Canales JJ; Zucchi R; Espinoza S; Sukhanov I; Gainetdinov RR
Expert Opin Ther Targets; 2018 Jun; 22(6):513-526. PubMed ID: 29798691
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases.
Ghaisas S; Maher J; Kanthasamy A
Pharmacol Ther; 2016 Feb; 158():52-62. PubMed ID: 26627987
[TBL] [Abstract][Full Text] [Related]
7. A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer's Disease.
Sun M; Ma K; Wen J; Wang G; Zhang C; Li Q; Bao X; Wang H
J Alzheimers Dis; 2020; 73(3):849-865. PubMed ID: 31884474
[TBL] [Abstract][Full Text] [Related]
8. Psychological comorbidity in gastrointestinal diseases: Update on the brain-gut-microbiome axis.
Person H; Keefer L
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Apr; 107():110209. PubMed ID: 33326819
[TBL] [Abstract][Full Text] [Related]
9. Bridging the Mind and Gut: Uncovering the Intricacies of Neurotransmitters, Neuropeptides, and their Influence on Neuropsychiatric Disorders.
Gupta S; Dinesh S; Sharma S
Cent Nerv Syst Agents Med Chem; 2024; 24(1):2-21. PubMed ID: 38265387
[TBL] [Abstract][Full Text] [Related]
10. Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain.
Xie Z; Miller GM
J Pharmacol Exp Ther; 2008 May; 325(2):617-28. PubMed ID: 18182557
[TBL] [Abstract][Full Text] [Related]
11. Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications.
Pei Y; Asif-Malik A; Canales JJ
Front Neurosci; 2016; 10():148. PubMed ID: 27092049
[TBL] [Abstract][Full Text] [Related]
12. Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer.
Vattai A; Akyol E; Kuhn C; Hofmann S; Heidegger H; von Koch F; Hermelink K; Wuerstlein R; Harbeck N; Mayr D; Spitzweg C; Toth B; Mahner S; Jeschke U; Ditsch N
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1637-1647. PubMed ID: 28409272
[TBL] [Abstract][Full Text] [Related]
13. Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics.
Revel FG; Moreau JL; Gainetdinov RR; Ferragud A; Velázquez-Sánchez C; Sotnikova TD; Morairty SR; Harmeier A; Groebke Zbinden K; Norcross RD; Bradaia A; Kilduff TS; Biemans B; Pouzet B; Caron MG; Canales JJ; Wallace TL; Wettstein JG; Hoener MC
Biol Psychiatry; 2012 Dec; 72(11):934-42. PubMed ID: 22705041
[TBL] [Abstract][Full Text] [Related]
14. Global research trends in microbiome-gut-brain axis during 2009-2018: a bibliometric and visualized study.
Zyoud SH; Smale S; Waring WS; Sweileh WM; Al-Jabi SW
BMC Gastroenterol; 2019 Aug; 19(1):158. PubMed ID: 31470803
[TBL] [Abstract][Full Text] [Related]
15. Protease-activated receptor signaling in intestinal permeability regulation.
Pontarollo G; Mann A; Brandão I; Malinarich F; Schöpf M; Reinhardt C
FEBS J; 2020 Feb; 287(4):645-658. PubMed ID: 31495063
[TBL] [Abstract][Full Text] [Related]
16. [Research progress of trace amine-associated receptor 1 signaling pathways].
Sun M; Zhang CC; Li JT; Si TM; Su YA
Sheng Li Xue Bao; 2024 Feb; 76(1):89-96. PubMed ID: 38444134
[TBL] [Abstract][Full Text] [Related]
17. Mind-altering with the gut: Modulation of the gut-brain axis with probiotics.
Kim N; Yun M; Oh YJ; Choi HJ
J Microbiol; 2018 Mar; 56(3):172-182. PubMed ID: 29492874
[TBL] [Abstract][Full Text] [Related]
18. Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms.
Felice VD; Quigley EM; Sullivan AM; O'Keeffe GW; O'Mahony SM
Parkinsonism Relat Disord; 2016 Jun; 27():1-8. PubMed ID: 27013171
[TBL] [Abstract][Full Text] [Related]
19. Trace Amines and Their Receptors.
Gainetdinov RR; Hoener MC; Berry MD
Pharmacol Rev; 2018 Jul; 70(3):549-620. PubMed ID: 29941461
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies.
Dedic N; Dworak H; Zeni C; Rutigliano G; Howes OD
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
